2 results
Approved WMOCompleted
Primary: To investigate the pharmacokinetics of palonosetron in plasma from three different sizes of HP-3020 transdermal patch applied for 24 hours as compared to intravenous palonosetron (Cohort 1) and to investigate the pharmacokinetics of…
Approved WMOCompleted
The primary objective of this study is to evaluate the safety and tolerability of trastuzumab emtansine.